Regulus Therapeutics

1 follower

‌

Regulus Therapeutics Inc. (Nasdaq:RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs.

Industries

Headquarters

Stage

Employees

Links

Org chart

Jay Hagan

President & CEO

Jay Hagan

Collapse

Preston S. Klassen

President & Head of Reserach & Development

Cris Calsada

CFO

Curtis Monnig

VP & CMC

Christopher Aker

SVP & General Counsel

Rekha Garg

SVP, Clinical Development & Regulatory

Claire Padgett

SVP, Clinical Operations

Amin Kamel

VP, Drug Metabolism & Pharmacokinetics

Brian Campion

VP, Business Development

Moh Ahmadian

VP, Chemistry & Pharmaceutical Development

Edmund Lee

VP, Translational Medicine

Teams

Legal and Compliance

9 members

Drug Development and Pharmacology

8 members

Leadership Team

6 members

Similar companies

Nkarta

1 follower

Summit Therapeutics

4 followers

Dermavant Sciences

3 followers

Sutro Biopharma

2 followers

EyePoint Pharmaceuticals

2 followers

Viridian Therapeutics

2 followers

Duke Corporate Education

6 followers

Keros Therapeutics

1 follower

Vividion Therapeutics

1 follower

ADMA Biologics

2 followers

PacBio

6 followers

Discover companies